Investment Rating - Buy (Maintained) [1] Core Views - The company's financial business remains stable, with industrial operations showing high growth, and its high dividend attribute is noteworthy [1] - The company's 2023 performance met expectations, with operating revenue reaching 37.96 billion yuan, a year-on-year increase of 3.76%, and net profit attributable to the parent company reaching 6.193 billion yuan, a year-on-year increase of 1.00% [2] - The company's financial and consulting segment saw a slight decline in interest income, but the financial services interest income increased by 3.64% to 22.467 billion yuan [3] - The industrial operations business achieved a revenue of 14.739 billion yuan, a year-on-year increase of 11.38%, with Hongxin Construction Development and Hongxin Health showing significant growth [3] - The company's net interest margin widened, and asset quality remained stable, with a non-performing asset ratio of 1.04%, a slight decrease from the previous year [3] Financial Performance and Valuation - The company's operating revenue is expected to grow steadily, with forecasts of 40.632 billion yuan, 43.046 billion yuan, and 45.504 billion yuan for 2024, 2025, and 2026, respectively [2] - Net profit attributable to the parent company is projected to be 6.649 billion yuan, 7.043 billion yuan, and 7.369 billion yuan for 2024, 2025, and 2026, respectively [2] - The EPS is expected to be 1.54 yuan, 1.63 yuan, and 1.71 yuan for 2024, 2025, and 2026, respectively [2] - The P/E ratio is forecasted to be 3.55, 3.35, and 3.20 for 2024, 2025, and 2026, respectively [2] Business Segments - Financial Services: Interest income from financial services increased by 3.64% to 22.467 billion yuan, with the average balance of interest-bearing assets increasing by 0.67% to 2.728 trillion yuan [3] - Industrial Operations: Revenue from industrial operations increased by 11.38% to 14.739 billion yuan, with Hongxin Construction Development and Hongxin Health contributing significantly [3] - Hongxin Construction Development expanded its overseas layout, with a management scale of 177,600 aerial work platforms, ranking first in Asia and top three globally [3] - Hongxin Health achieved a net profit of 170 million yuan, a year-on-year increase of 253%, by optimizing its hospital portfolio and improving management efficiency [3] Market Data - The closing price of the stock is 6.35 HKD, with a one-year low/high of 4.96/7.38 HKD [5] - The P/B ratio is 0.55, and the market capitalization is 27.401 billion HKD [5] Financial Indicators - The company's net asset per share is 11.61 HKD, with a debt-to-asset ratio of 83.62% [6] - The total share capital is 4.315 billion shares, with the same number of shares in circulation [6] Related Research - Previous reports have highlighted the company's special dividends and the strategic foresight of Hongxin Construction Development's listing [7]

Financial Performance - For the third quarter of 2023, the company achieved a slight year-on-year increase in operating revenue and net profit attributable to ordinary shareholders[1]. Asset Management - The total amount of interest-earning assets at the end of the period showed a slight increase compared to the beginning of 2023, with a stable asset quality and non-performing asset ratio[1]. Risk Management - The company maintained a prudent risk management strategy, with effective foreign exchange hedging measures and stable liquidity conditions[2]. Strategic Development - The company plans to continue its "Finance + Industry" development strategy, prioritizing operational safety and efficiency improvements[2]. Stock Options - The number of stock options granted under all stock option plans in 2022 was 33,847,932, representing approximately 0.0081% of the weighted average number of shares issued during the year[3].

Financial Performance - Total revenue for the six months ended June 30, 2023, reached RMB 18,361,807 thousand[9] - Profit attributable to ordinary shareholders for the same period was RMB 3,070,724 thousand[9] - Basic earnings per share for the six months ended June 30, 2023, was RMB 0.73[9] - Diluted earnings per share for the same period was RMB 0.66[10] - Total revenue for the six months ended June 30, 2023, was RMB 18,361,807 thousand, an increase from RMB 17,715,854 thousand in the same period of 2022, representing a growth of 3.65%[12] - Financial services (interest income) amounted to RMB 11,084,837 thousand, up from RMB 10,517,904 thousand year-over-year, reflecting a growth of 5.41%[12] - In the first half of 2023, the company achieved a net profit attributable to ordinary shareholders of RMB 3,070,724 thousand, an increase of 8.19% compared to the same period last year[28] - Basic earnings per share for the first half of 2023 was RMB 0.73, compared to RMB 0.68 in the same period of 2022, marking an increase of 7.35%[12] - The company's gross profit decreased by 5.10% to RMB 8,452,581 thousand, while sales costs increased by 12.49% to RMB 9,909,226 thousand[29] Asset Management - The company's total assets as of June 30, 2023, reached RMB 361,362,852 thousand, compared to RMB 358,485,563 thousand in the previous year, indicating a slight increase of 0.52%[13] - The total equity attributable to ordinary shareholders increased to RMB 47,327,470 thousand as of June 30, 2023, from RMB 42,180,697 thousand in the previous year, reflecting a growth of 12.77%[13] - Cash and cash equivalents increased by 34.45% to RMB 21,382,384 thousand compared to RMB 15,903,843 thousand at the end of the previous year[75] - The company's loan and receivables amounted to RMB 276,744,255 thousand, accounting for 76.59% of total assets, with a year-on-year increase of 3.60%[75] - The total amount of non-performing assets was RMB 2,928,744 thousand, up from RMB 2,831,337 thousand at the end of 2022[117] Risk Management - The company has implemented a five-level classification system for interest-bearing assets to effectively manage and control asset quality and risks[91] - The company emphasizes a proactive approach to risk management, combining online predictive models with offline manual verification for accurate risk assessment[96] - The non-performing asset ratio remained stable at 1.05% as of June 30, 2023, unchanged from the end of 2022, reflecting controlled overall asset quality[104] - The company has upgraded its risk prediction model using big data and AI algorithms, achieving early warning capabilities of 1 to 3 months for identifying risk enterprises[96] - The provision coverage ratio decreased to 234.87% from 239.97% at the end of 2022[115] Market Presence and Strategy - The company aims to integrate industrial and financial services to support sustainable economic development[6] - The company plans to continue expanding its market presence and investing in new technologies to enhance operational efficiency and service offerings[15] - The company is actively adjusting its service structure to meet customer demands in response to the declining consulting service revenue[39] - The company plans to maintain stable growth in traditional financial services while achieving rapid growth in industrial operations and innovative financial services[72] - The company aims to strengthen its understanding of macroeconomic trends and industry dynamics to better navigate market challenges[178] Healthcare Operations - The healthcare segment saw a significant increase in patient visits and hospital admissions, capitalizing on the post-pandemic recovery[26] - The company plans to continue expanding its healthcare services in county-level markets, aiming to build the largest county health service platform in China[26] - The group operates 29 hospitals with approximately 11,000 open beds, covering regions including East China, South China, North China, Southwest, and Northeast, enhancing its national hospital operation network[200] - The group completed the equity transfer of Zhengzhou Renji Hospital in the first half of 2023, continuing to optimize asset efficiency and accelerate strategic upgrades[200] - The healthcare sector accounted for 16.50% of total assets, increasing from 15.59% at the end of 2022[121] Financing and Capital Structure - The group’s total assets at the beginning of the year were RMB 2,831,337 thousand, showing an increase to RMB 2,928,744 thousand by the end of the period[112] - The total liabilities of the group reached RMB 304,900,349 thousand, an increase of RMB 10,346,274 thousand or 3.51% compared to the end of the previous year[131] - The group's offshore financing increased significantly by 32.88% to RMB 56,972,723 thousand as of June 30, 2023, compared to RMB 42,873,721 thousand at the end of 2022[144] - The company has issued perpetual securities totaling RMB 1,000,000,000 with an initial distribution rate of 4.2% on July 6, 2022[153] - The company plans to potentially issue new perpetual securities based on market conditions and financing needs in the future[156]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立的有限公司） （股份代號：3360） 截至二零二三年六月三十日止六個月中期業績公告 遠東宏信有限公司（「本公司」）董事局（「董事局」）謹此公佈本公司及其附屬公司 （「本集團」）截至二零二三年六月三十日止六個月的未經審核中期業績，連同截至 二零二二年六月三十日止六個月的比較數字。本公告列載本公司二零二三年中期 報告全文，並符合香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規 則」）中有關中期業績初步公告附載的資料之要求。 承董事局命 遠東宏信有限公司 主席、行政總裁及執行董事 孔繁星 香港，二零二三年八月九日 於本公告日期，本公司執行董事為孔繁星先生（主席）、王明哲先生及曹健先生； 本公司非執行董事為陳樹民先生、衛濛濛女士、劉海峰先生、郭明鑑先生及羅強 ...

Financial Performance - In 2022, the company's revenue and profitability continued to grow, supported by a resilient Chinese economy with a GDP growth of 3%[11] - The total revenue for the year 2022 reached approximately RMB 36.59 billion, an increase of 8.74% compared to the previous year[14] - The net profit attributable to ordinary shareholders was approximately RMB 6.13 billion, reflecting a year-on-year growth of 11.23%[14] - The company’s total assets amounted to RMB 346.99 billion, representing a growth of about 3.31% year-on-year[14] - The average return on equity was 14.13%, maintaining stable returns[14] - Basic earnings per share rose to RMB 1.46, an increase of 7.4% from RMB 1.36 in the previous year[19] - The company's net profit attributable to ordinary shareholders was RMB 6,131,474 thousand, representing a 11.2% increase compared to RMB 5,512,245 thousand in 2021[19] - The average return on assets for 2022 was 1.93%, a slight decrease from 1.96% in 2021[19] - The company reported a net interest margin of 4.67%, an increase from 4.06% in the previous year[19] - The group's total sales cost for the year 2022 was RMB 18,127,725 thousand, an increase of 10.32% from RMB 16,431,419 thousand in 2021[68] - The group's gross profit for 2022 was RMB 18,457,997 thousand, up by RMB 1,245,493 thousand or 7.24% from RMB 17,212,504 thousand in 2021, with gross margins of 50.45% and 51.16% respectively[78] Business Strategy and Operations - The company operates under a "Finance + Industry" strategic framework, focusing on serving enterprise clients and deepening strategic development[11] - The company has established a development positioning of "backed by the mainland, based in Hong Kong, and radiating Southeast Asia" to enhance its market presence[11] - The company has expanded its operational network across major cities in China, including Shanghai, Tianjin, and others, to improve customer service[8] - The company has a diversified business model that integrates financial and industrial capital across various sectors, including healthcare, construction, and logistics[7] - The company emphasizes innovation in products and services to provide tailored comprehensive operational services for clients[7] - The company has focused on technological advancements, implementing various digital tools to enhance operational efficiency and risk management[41] - The company expanded its business departments from 21 to 27 and increased its offices from 27 to 31, enhancing regional support and customer coverage[41] - The company plans to enhance medical services in under-resourced areas and expand into dental and aesthetic medical services[44] - The company plans to spin off its subsidiary, Hongxin Jianfa, for independent listing on the Hong Kong Stock Exchange, which is expected to reduce the debt-to-asset ratio to 84.42%[24] Market and Economic Conditions - Domestic demand showed negative growth with retail sales of consumer goods at RMB 44.0 trillion, a year-on-year decline of 0.2% compared to a 12.5% increase the previous year[32] - Fixed asset investment (excluding rural households) reached RMB 57.2 trillion, growing by 5.1% year-on-year, with infrastructure investment increasing by 9.4% and manufacturing investment by 9.1%[32] - The contribution of net exports to GDP growth was 17.1%, adding 0.5 percentage points, but in Q4, net exports negatively impacted GDP by 1.2 percentage points due to external demand contraction and pandemic disruptions[32] - By the end of 2022, the broad money supply (M2) grew by 11.8% year-on-year, while the total social financing stock increased by 9.6%[34] Asset Quality and Risk Management - The company’s asset quality improved, with the non-performing asset ratio decreasing to 1.05%[12] - The non-performing asset ratio improved to 1.05%, down from 1.06% in the previous year[22] - The proportion of attention-class assets decreased to 7.00% in 2022 from 8.09% in 2021, indicating an improvement in asset quality[129] - The healthcare sector accounted for 14.44% of total attention-class assets, down from 16.11% in the previous year, reflecting the impact of regional pandemic measures[132] - The company upgraded its risk warning system, enhancing the classification model and push frequency of risk information, which improved the timeliness and accuracy of risk data[126] - The company established a leading litigation information management system covering the entire process from filing to execution, enhancing litigation efficiency[126] - The company’s localized asset disposal teams played a crucial role in risk asset management during the pandemic, ensuring rapid response capabilities[125] Shareholder Value and Dividends - The company expresses gratitude to shareholders for their support, which has been crucial for its continued value creation[11] - The company plans to distribute a dividend of HKD 0.49 per share, reaffirming its commitment to shareholder value[14] - The company declared a final dividend of HKD 0.42 per share, which was approved at the annual general meeting on June 8, 2022, and paid on June 30, 2022[191] Financing and Capital Structure - The company issued asset-backed securities including three green bonds and one rural modernization themed product in 2022, enhancing its financing capabilities[172] - The company issued perpetual securities totaling RMB 1,000,000 thousand on July 6, 2022, with an initial distribution rate of 4.2%[194] - The company has outstanding convertible bonds with a principal amount of USD 300,000,000, maturing in 2025, with an annual interest rate of 2.5%[197] - The company plans to issue additional perpetual securities in the future based on market conditions and financing needs[196] - The total liabilities as of December 31, 2022, amounted to RMB 294,554 million, an increase of 4.15% from RMB 282,826 million at the end of the previous year[170] - The total equity of the group as of December 31, 2022, was RMB 52,439,513 thousand, a decrease of RMB 614,597 thousand or 1.16% from the previous year[189] Sector-Specific Performance - The healthcare segment generated revenue of RMB 101 million, down 85.63% from RMB 703 million in 2021, representing only 1.73% of total revenue[52] - The urban public utilities segment remained the largest contributor, accounting for 60.11% of total revenue with RMB 3,519 million, a slight decrease of 5.50% from RMB 3,724 million in 2021[52] - The industrial operations segment achieved revenue of RMB 13,232,942 thousand, a 15.73% increase from the previous year, accounting for 36.02% of total revenue[65] - The financial and consulting segment generated revenue of RMB 23,500,076 thousand, accounting for 63.98% of total revenue, with a growth of 5.16% year-on-year[50]

Financial Performance - Total revenue for the six months ended June 30, 2022, was RMB 17,715,854, representing an increase from RMB 16,184,157 for the same period in 2021, which is a growth of approximately 9.5%[16]. - Profit attributable to ordinary shareholders for the six months ended June 30, 2022, was RMB 2,842,245, up from RMB 2,572,885 in the same period of 2021, reflecting an increase of about 10.5%[16]. - Basic earnings per share for the six months ended June 30, 2022, was RMB 0.68, compared to RMB 0.64 for the same period in 2021, indicating a growth of 6.25%[16]. - The diluted earnings per share for the same period was RMB 0.62[17]. - The pre-tax profit for the first half of 2022 was RMB 4,559,280 thousand, an increase of 8.36% from RMB 4,207,417 thousand in the previous year[40]. - The net profit attributable to ordinary shareholders was RMB 2,842,245 thousand, reflecting a growth of 10.47% compared to RMB 2,572,885 thousand in the prior year[41]. - The gross profit for the first half of 2022 was RMB 8,907,138 thousand, representing an increase of 8.47% from RMB 8,211,587 thousand in the same period of 2021[63]. - The net profit for the period was RMB 287.05 million, representing a 16.53% increase from RMB 246.33 million[191]. Revenue Breakdown - Financial services (interest income) contributed RMB 10,517,904, up from RMB 9,358,025 year-on-year, indicating a growth of 12.4%[20]. - The financial and consulting segment generated revenue of RMB 11,596,385 thousand, accounting for 65.17% of total revenue, with a year-on-year increase of 4.17%[44]. - The industry operation segment reported revenue of RMB 6,197,942 thousand, marking a significant growth of 21.13% from RMB 5,116,738 thousand in the previous year[45]. - Total revenue for the equipment operation segment reached RMB 3,565.17 million, a 46.73% increase compared to RMB 2,429.70 million in the previous year[191]. - Total revenue for the hospital operations segment reached RMB 2,067.03 million, a 4.05% increase from RMB 1,986.54 million in the previous year[196]. Asset and Liability Management - The total assets as of June 30, 2022, reached RMB 358,485,070, up from RMB 333,554,753 in the same period last year, marking a growth of 7.0%[21]. - The total liabilities increased to RMB 309,020,789 from RMB 285,175,866, representing a rise of 8.5%[21]. - The company's total equity for the group was RMB 49,464,281 thousand, a decrease of RMB 3,589,829 thousand or 6.77% compared to the end of the previous year[133]. - The total amount of non-performing assets reached 3,020,332 thousand RMB as of June 30, 2022, compared to 2,751,412 thousand RMB at the end of 2021[105]. - The provision coverage ratio for non-performing assets was 236.30% as of June 30, 2022, slightly down from 241.75% at the end of 2021[110]. Operational Efficiency - The company aims to enhance operational efficiency and management effectiveness while emphasizing differentiated competitive advantages in the market[38]. - The company plans to enhance operational efficiency through group management to better convert sales costs into revenue growth[56]. - The company is focusing on enhancing operational efficiency in inclusive finance, overseas business, PPP investments, and non-performing asset management to ensure high-quality and stable development[37]. - The company plans to enhance operational efficiency and strategic focus in the second half of 2022, aiming for sustainable development[190]. Risk Management - The company maintains a proactive approach to managing asset quality through a five-tier classification system to assess risk and ensure effective resource allocation[92]. - The company has implemented a comprehensive asset management policy, resulting in a continuous improvement in asset quality and safety[98]. - The company emphasizes risk management by integrating industry research with evaluation practices, creating an industry management manual to enhance risk recognition[162]. - The company is committed to optimizing asset allocation by diversifying across industries, regions, and clients, adhering to a principle of reasonable risk dispersion[160]. Financing and Capital Structure - The company issued two green bonds and one rural agricultural modernization asset securitization project in the first half of 2022, supporting sustainable development[124]. - The company completed the issuance of RMB 1 billion perpetual medium-term notes in July 2022, indicating a focus on innovative financing products[124]. - The company has sufficient credit lines from banks, ensuring the ability to repay bondholders in cash if required[145]. - The company plans to potentially issue new perpetual securities based on market conditions and financing needs in the future[133]. Employee and Talent Management - The company has established an effective employee incentive plan linking compensation to overall performance and contributions, rather than just operational results[177]. - The company aims to attract and retain top management talent through its equity incentive plans established in 2014 and 2019[177]. - The company had 23,013 full-time employees as of June 30, 2022, an increase of 571 from the previous year, with approximately 41.9% holding bachelor's degrees or higher[176].

Financial Performance - The company reported a strong performance in 2021, achieving significant financial results despite a challenging external environment [15]. - The total revenue for the year reached approximately 10 billion RMB, reflecting a year-on-year growth of 15% [12]. - The net profit attributable to ordinary shareholders for the year was approximately RMB 5.512 billion, representing a year-on-year growth of about 20.47% [19]. - The total operating revenue for the year was approximately RMB 33.644 billion, reflecting a year-on-year growth of about 15.85% [19]. - Profit attributable to ordinary shareholders for 2021 was RMB 5,512,245 thousand, up from RMB 4,575,751 thousand in 2020, reflecting a year-over-year increase of about 20.5% [23]. - The average return on equity reached 14.57%, further improving from the previous year [19]. - The average return on assets for 2021 was 1.96%, an improvement from 1.80% in 2020 [22]. - The pre-tax profit reached RMB 10,013,298 thousand, an increase of 33.38% from RMB 7,507,546 thousand in the previous year [39]. - The group's gross profit for 2021 was RMB 17,212,504 thousand, a 15.01% increase from RMB 14,965,635 thousand in 2020 [63]. Revenue Segments - The revenue from the industrial operation segment reached RMB 11.435 billion, an increase of 29.78% year-on-year, accounting for 33.85% of total operating revenue [19]. - The financial and consulting segment generated revenue of RMB 22,347,264 thousand, accounting for 66.15% of total revenue, with a year-on-year increase of 9.77% [41]. - The revenue from equipment operations within the industrial operations segment surged by 67.63% to RMB 6.141 billion [53]. - The hospital operations revenue increased by 16.13% to RMB 4.003 billion, maintaining a significant share of the industrial operations segment [53]. - Operating lease income increased by 79.64% to RMB 4,463.35 million in 2021, compared to RMB 2,484.55 million in 2020 [189]. Asset Management - As of the end of 2021, the total interest-earning assets of the group reached RMB 258.379 billion, an increase of approximately 9.76% compared to the beginning of the year [18]. - The average balance of interest-earning assets rose by 13.99% to RMB 251.707 billion, indicating effective asset management [47]. - The total assets of the group reached RMB 335.880 billion, an increase of approximately 11.99% compared to the same period last year [19]. - The proportion of interest-earning assets in total assets was 74.95% as of December 31, 2021 [84]. - The total amount of interest-earning assets overdue for more than 30 days was RMB 2,420,952 thousand, with the healthcare sector accounting for 16.43% of this total [119]. Strategic Initiatives - The company plans to invest 1 billion RMB in new product development and technology innovation over the next three years [15]. - A focus on mergers and acquisitions is anticipated, aiming to strengthen the company's market position and diversify its service portfolio [15]. - The company emphasizes a "Finance + Industry" strategy to align with national development goals and enhance service capabilities [15]. - The company is expanding its service functions in inclusive finance, PPP investment, asset management, overseas business, and PE investment, broadening its operational boundaries [35]. - The company aims to enhance risk management by optimizing asset allocation and focusing on industries related to urban and industrial upgrades [165]. Risk Management - The non-performing asset ratio stood at 1.06%, with a provision coverage ratio exceeding 240% [18]. - The company has enhanced its risk information management through technological upgrades, improving the efficiency of risk asset disposal [99]. - The company has adopted a prudent asset classification policy, maintaining strict monitoring of "attention" assets to minimize migration to non-performing status [102]. - The company is focusing on industry-specific asset management systems to optimize asset structure and reduce risk impacts [100]. - The overdue rate for interest-earning assets over 30 days as of December 31, 2021, was 0.94%, a decrease of 0.05 percentage points from 0.99% at the end of 2020 [118]. Future Outlook - Future outlook remains positive, with a projected revenue growth of 12% for 2022, driven by strategic market expansions and new service offerings [15]. - The company anticipates a significant recovery in consumer spending as the domestic demand strategy is implemented in 2022 [107]. - The company aims to maintain a strong credit rating and robust capital ratios to support its business and maximize shareholder value [155]. - The company is committed to developing new customer bases and expanding its service depth across various customer segments, including state-owned and private enterprises [166]. Corporate Governance - The group is committed to enhancing corporate governance standards, which are crucial for sustainable development and shareholder value [199]. - The company emphasizes a healthy corporate culture as a core aspect of good governance, promoting accountability and ethical behavior among all employees [200]. - The company has established equity incentive plans to attract and retain talented management, ensuring alignment of shareholder and company interests [183].

Financial Performance - Total revenue for the six months ended June 30, 2020, was RMB 13,275,366 thousand, a decrease of 6.4% compared to RMB 14,181,427 thousand for the same period in 2019[11]. - Basic earnings per share for the six months ended June 30, 2020, was RMB 0.54, down from RMB 0.58 in 2019, representing a decline of 6.9%[11]. - The net profit attributable to ordinary shareholders for the six months was RMB 2,055,682 thousand, a decrease of 8.0% from RMB 2,233,436 thousand in the previous year[16]. - The average return on assets was 1.72%, down from 1.93% in the same period last year[16]. - The gross profit margin decreased to 51.0% in the first half of 2020, down from 56.5% in the same period last year[29]. - The company's net profit for the first half of 2020 was RMB 206.51 million, a decrease of 7.42% from RMB 223.05 million in the previous year, primarily due to the impact of COVID-19[186]. Revenue Breakdown - Financial services (interest income) contributed RMB 7,730,045 thousand, down from RMB 8,163,767 thousand, reflecting a decline of 5.3% year-over-year[16]. - The financial and consulting segment's revenue was RMB 9,699,212 thousand, accounting for 72.82% of total revenue, which represents a decline of 13.73% year-on-year[31]. - The healthcare segment generated RMB 3,320 million, accounting for 12.92% of total revenue, down 37.38% from RMB 5,302 million in 2019[113]. - The urban utilities segment saw an increase in revenue to RMB 9,898 million, representing 38.52% of total revenue, up 5.34% from RMB 9,396 million in 2019[113]. - Total revenue for the hospital operations segment reached RMB 1,534.56 million, a 15.19% increase from RMB 1,332.16 million in the same period last year[180]. Cost and Expenses - Cost of sales for the same period was RMB 6,500,950 thousand, up from RMB 6,162,222 thousand in 2019, reflecting an increase of 5.5%[11]. - The company's operating expenses decreased by 16.24% to RMB 2,361,302 thousand compared to RMB 2,819,296 thousand in the same period last year[29]. - The total cost of hospital operations increased by 20.39% to RMB 1,201.38 million from RMB 997.93 million in the prior year[180]. - The cost of the financial and consulting segment was RMB 3,980,399 thousand, down 5.03% from RMB 4,191,318 thousand in the previous year[48]. Asset and Liability Management - The asset-liability ratio was 84.21% as of June 30, 2020, slightly improved from 84.50% in 2019[13]. - The total assets as of June 30, 2020, amounted to RMB 289,317,456 thousand, an increase of 11.6% compared to RMB 259,235,096 thousand in 2019[17]. - The total liabilities increased to RMB 243,624,474 thousand, up from RMB 219,051,277 thousand, representing an increase of 11.3%[17]. - Cash and cash equivalents increased by 99.84% to RMB 7,972,789 thousand compared to RMB 3,989,571 thousand at the end of the previous year[76]. Market and Economic Environment - The overall economic environment showed signs of recovery, with GDP declining by 1.6% year-over-year, but the company remains cautious about future performance due to ongoing uncertainties[20]. - The broad money supply and social financing scale increased by 11.1% and 12.8% respectively in the first half of the year[22]. - The one-year Loan Prime Rate (LPR) was reduced by 30 basis points to 3.85% since the beginning of the year[22]. Strategic Initiatives - The company aims to enhance its integrated operational services in various sectors including healthcare, cultural tourism, and engineering construction[8]. - The company plans to enhance its market expansion strategies and invest in new technologies to adapt to the changing economic environment[20]. - The company is focused on innovation in products and services to provide tailored solutions for clients[8]. - The company is advancing new business areas such as inclusive finance, supply chain finance, and asset management, with personnel and systems being established[25]. Risk Management - The company has implemented risk management measures in response to the COVID-19 pandemic, including asset risk assessments and adjustments to new business strategies[142]. - The company has focused on enhancing its risk disposal capabilities by expanding regional disposal resources and exploring new disposal methods[92]. - The company has adopted flexible methods for client verification, including phone and video verification, to ensure reliable and safe assessments despite travel restrictions[147]. Human Resources - The workforce increased to 20,935 full-time employees by June 30, 2020, a rise of 6,164 from the previous year, primarily in healthcare and equipment operations[160]. - Approximately 44.70% of employees hold a bachelor's degree or higher, while about 17.50% possess a master's degree or above, indicating a highly educated workforce[160]. - The company has established an employee incentive plan linking compensation to overall performance and contributions, aiming to attract and retain talent[161]. Corporate Governance - The company has complied with the corporate governance code throughout the reporting period, except for the attendance of the chairman at the annual general meeting[198]. - The governance structure includes a strategic and investment committee chaired by Liu Haifeng, ensuring oversight of investment decisions[198].

遠 東 宏 信 FAR EAST HORIZON 20 19 年度 報告 imming || | 01 pen ::::: 000 000 000 於香港註冊的有限公司 股票代碼 : 3360 af 1977 r and a 分出社会在中古 上一 s a de 2019 年度報告 公司簡介 上班 : 近業信息 攻鬆就就職 理 冒訪論與分析 · · · . . . . · · · · · . • · · • · . · · • • · · · · · • · · • • • · · · 4 6 8 10 13 18 目 參 HER 遠東宏信有限公司 | --- | --- | --- | --- | --- | --- | |-------|-------|----------------------|----------|----------------|---------| | | | | | | | | | | | | | | | | 联 曾 | 『及高級管理人員嘗歷 | 事局報告 | 業 社 章 性 | 務 報告 | | | | | | | | | | | | | | | | | . | | | | | ...